Understanding immune reactivity against SARS-CoV-2 is essential for coping with the
COVID-19 pandemic. Herein, we discuss experiences and open questions about the …

Multiple severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccines have
been approved for clinical use. SARS-CoV-2 neutralizing antibody titers after immunization …

The emergence of novel variants of SARS-CoV-2 and their abilities to evade the immune
response elicited through presently available vaccination makes it essential to recognize the …

Understanding the T cell response to SARS-CoV-2 is critical to vaccine development,
epidemiological surveillance, and control strategies for this disease. This review provides …

The novel coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is
the causative agent of the ongoing pandemic of coronavirus disease 2019 (COVID-19). The …

SARS-CoV-2-specific T cell response has been proven essential for viral clearance, COVID-
19 outcome and long-term memory. Impaired early T cell-driven immunity leads to a severe …

The coronavirus disease 2019 (COVID-19) pandemic, caused by severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) has affected millions of people worldwide, igniting …

COVID-19 vaccines have significantly decreased the number of severe cases of the disease,
but the virus circulation remains important, and questions about the need of new vaccination …

Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) and its mechanisms have
been thoroughly studied by researchers all over the world with the hope of finding answers …

Recently, the protective and/or pathological role of virus-specific T cells in SARS-CoV-2
infection has been the focus of many studies. We investigated the anti-spike IgG levels and …